Results 271 to 280 of about 100,759 (296)
Some of the next articles are maybe not open access.

Review on Nose-To-Brain Drug Delivery

A major limiting factor for the treatment of central nervous system (CNS) related diseases is the incapability for medicine substances to cross the blood- brain hedge. Some specifics may retain cure- limiting systemic side goods that hamper their capability to reach maximum effective attention in the CNS.
openaire   +1 more source

Particulate carriers for nose-to-brain delivery

2021
Shiv Bahadur, Kamla Pathak
openaire   +1 more source

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov   +2 more
exaly  

Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?

Ca-A Cancer Journal for Clinicians, 2021
Pelin Cinar, Daniela A Bota, Emad Elquza
exaly  

BNN27 nanoformulations for nose-to-brain delivery

2023
Maria Kannavou   +8 more
openaire   +1 more source

NANOEMULSION: DIRECT NOSE-TO-BRAIN DELIVERY

World Journal of Pharmacy and Pharmaceutical Sciences, 2017
openaire   +1 more source

Home - About - Disclaimer - Privacy